|
|
Volumn 33, Issue , 2015, Pages 105-112
|
|
Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons
a
b,c
a,b
|
|
Author keywords
Antibiotics Probiotics; Fecal transplantation; Inflammatory bowel disease; Microbiota; Prebiotics
|
|
Indexed keywords
ABIOTIC AGENT;
ANTIBIOTIC AGENT;
MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE;
PREBIOTIC AGENT;
PROBIOTIC AGENT;
SYNBIOTIC AGENT;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIAL STRAIN;
CLINICAL EVALUATION;
CONTROLLED CLINICAL TRIAL (TOPIC);
CROHN DISEASE;
DRUG EFFICACY;
DRUG TARGETING;
FECAL MICROBIOTA TRANSPLANTATION;
HUMAN;
INFLAMMATION;
INFLAMMATORY BOWEL DISEASE;
INTESTINE FLORA;
META ANALYSIS (TOPIC);
MULTICENTER STUDY (TOPIC);
NONHUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TRANSGENIC ORGANISM;
TRANSPLANTATION;
ULCERATIVE COLITIS;
|
|
EID: 84942102435
PISSN: 02572753
EISSN: 14219875
Source Type: Journal
DOI: 10.1159/000437104 Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
